A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug
Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug
Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem'
Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem'
Roche reports another phase 3 multiple sclerosis win, but deaths add to safety questions
Roche reports another phase 3 multiple sclerosis win, but deaths add to safety questions
Chutes & Ladders—Roche taps Aussie oncologist to lead early research
Chutes & Ladders—Roche taps Aussie oncologist to lead early research
Roche’s Genentech cut at least 489 jobs last year, new disclosure reveals
Roche’s Genentech cut at least 489 jobs last year, new disclosure reveals
Roche's return to RNA continues with $1.7B deal for Sanegene program
Roche's return to RNA continues with $1.7B deal for Sanegene program
Roche diagnostics business nudges up 2% in '25 as China headwinds buffet Asia-Pacific sales
Roche diagnostics business nudges up 2% in '25 as China headwinds buffet Asia-Pacific sales
Chutes & Ladders—Former Roche oncology head turns to Tubulis
Chutes & Ladders—Former Roche oncology head turns to Tubulis
Roche returns to MediLink with promise of $570M near-term payments for another ADC
Roche returns to MediLink with promise of $570M near-term payments for another ADC
In Structure licensing deal, Roche commits $100M to shore up GLP-1 position
In Structure licensing deal, Roche commits $100M to shore up GLP-1 position
Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial
Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial
Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche’s Flatiron
Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche’s Flatiron
Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge
MEDTECH Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge By Conor Hale Dec 2, 2025 10:55am Roche whooping cough pertussis diagnostic...
<a href="https://www.fiercebiotech.com/medtech/roche-inks-200m-licensing-pact-freenomes-cancer-screening-blood-tests" hreflang="en">Roche inks $200M-plus licensing pact for Freenome's cancer screening blood tests</a>
Roche will make a new $75 million equity investment in Freenome, toward the goal of developing blood testing kits for markets outside the U.S.
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page